Skip to main content
Top

Hepatology International

Issue 1/2020

Content (15 Articles)

Fatty Liver Review Article

New drugs for NAFLD: lessons from basic models to the clinic

Katharina C. Reimer, Alexander Wree, Christoph Roderburg, Frank Tacke

Open Access Rifaximin Review Article

Antimicrobial resistance in chronic liver disease

Vishal C. Patel, Roger Williams

Hepatitis B Review Article

Use of HBsAg quantification in the natural history and treatment of chronic hepatitis B

Lung-Yi Mak, Wai-Kay Seto, James Fung, Man-Fung Yuen

Hepatitis B Original Article

Dynamic changes of T cell receptor repertoires in patients with hepatitis B virus-related acute-on-chronic liver failure

Guojun Shen, Shuilin Sun, Jie Huang, Haohui Deng, Ying Xu, Zhanhui Wang, Xiong Tang, Xiaodong Gong

Liver Transplantation Original Article

Nucleoside analog monotherapy for prophylaxis in Hepatitis B liver transplant patients is safe and efficacious

Mark D. Muthiah, En Ying Tan, Sin Hui Melissa Chua, Daniel Q. Y. Huang, Glenn K. Bonney, Alfred W. C. Kow, Seng Gee Lim, Yock Young Dan, Poh Seng Tan, Guan Huei Lee, Boon Leng Lim

Retrospective comparison of EASL 2018 and LI-RADS 2018 for the noninvasive diagnosis of hepatocellular carcinoma using magnetic resonance imaging

Sunyoung Lee, Myeong-Jin Kim, Seung-seob Kim, Hyejung Shin, Do Young Kim, Jin-Young Choi, Mi-Suk Park, Donald G. Mitchell

Targeting adenosinergic pathway enhances the anti-tumor efficacy of sorafenib in hepatocellular carcinoma

Jing Liao, Dan-Ni Zeng, Jin-Zhu Li, Qiao-Min Hua, Zhiyu Xiao, Chuanchao He, Kai Mao, Ling-Yan Zhu, Yifan Chu, Wei-Ping Wen, Limin Zheng, Yan Wu

Cholangiocarcinoma Original Article

Improving pathological early diagnosis and differential biomarker value for hepatocellular carcinoma via RNAscope technology

Ahmed Musa Hago Bakheet, Chang Zhao, Jian-Ning Chen, Jing-Yue Zhang, Jun-Ting Huang, Yu Du, Li-Ping Gong, Yuan-Hua Bi, Chun-Kui Shao

Hepatitis B Original Article

Tenofovir versus entecavir in lowering the risk of hepatocellular carcinoma development in patients with chronic hepatitis B: a critical systematic review and meta-analysis

Min Li, Tingting Lv, Shanshan Wu, Wei Wei, Xiaohai Wu, Xiaojuan Ou, Hong Ma, Shein-Chung Chow, Yuanyuan Kong, Hong You, Jidong Jia

Open Access Sarcopenia Original Article

Relationship between relative skeletal muscle mass and nonalcoholic fatty liver disease: a systematic review and meta-analysis

Changzhou Cai, Xin Song, Yishu Chen, Xueyang Chen, Chaohui Yu

Open Access Alpha-1 Antitrypsin Deficiency Original Article

Liver organoids reproduce alpha-1 antitrypsin deficiency-related liver disease

Gema Gómez-Mariano, Nerea Matamala, Selene Martínez, Iago Justo, Alberto Marcacuzco, Carlos Jimenez, Sara Monzón, Isabel Cuesta, Cristina Garfia, María Teresa Martínez, Meritxell Huch, Ignacio Pérez de Castro, Manuel Posada, Sabina Janciauskiene, Beatriz Martínez-Delgado

Hepatic Encephalopathy Original Article

Ascitic fluid infection in children with liver disease: time to change empirical antibiotic policy

Sumit Kumar Singh, Ujjal Poddar, Richa Mishra, Anshu Srivastava, Surender Kumar Yachha

Original Article

TAF and TDF attenuate liver fibrosis through NS5ATP9, TGFβ1/Smad3, and NF-κB/NLRP3 inflammasome signaling pathways

Jing Zhao, Ming Han, Li Zhou, Pu Liang, Yun Wang, Shenghu Feng, Hongping Lu, Xiaoxue Yuan, Kai Han, Xiaofan Chen, Shunai Liu, Jun Cheng

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.